Syneos Health, Inc.

Syneos Health, Inc. is a Humankind 100 company whose ranking is based on its Humankind Value, a proprietary metric that provides an estimate of the overall dollar amount a company creates for investors, consumers, employees, and society at large.

Syneos health is a fully integrated biopharmaceutical solutions provider. The company specializes in delivering clinical and commercial capabilities and solutions.

Ticker: SYNH

Humankind Value: $43.1 B

Revenue: $4.5 B

Market Cap: $7.5 B

(All values are in US Dollars, where M=Million, B=Billion, T=Trillion.)

Healthcare is a central component of our measure of Humankind Value, as a large contribution to modern life expectancies has come from the last 150 years of medical innovation. Syneos Health, Inc. is responsible for positive Humankind Value, primarily due to Healthcare R&D ($29.0 B), Pharmaceuticals ($13.3 B), and Economic Value ($2.3 B). The value associated with Healthcare R&D and Pharmaceuticals is linked to an estimate of 877,253.5 additional years lived by people worldwide. It also produces economic value by offering to consumers goods and services that they value, paying employees for their labor in producing these goods and services, and providing value for shareholders. Downsides for this company are associated with Calorie Conversion (-$2.3 B) and Opioid Abuse (-$1.7 B). Healthcare R&D, Pharmaceuticals, Economic Value, Calorie Conversion, and Opioid Abuse are mostly or entirely a result of supply-chain relationships. For this firm, supply chain partners increase an already positive Humankind Value.

How the Humankind Value Methodology Drives the Rankings

We take a quantitative, data-driven approach to estimating the economic impact that companies have on investors, customers, employees, and society at large, rolling social responsibility into a single dollar value that we use to represent what a company is contributing to humanity. As far as we can tell, we're the first ones doing it this way.

How Methodology Drives the Rankings